Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial

Overview of attention for article published in The Lancet, May 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news: 29 news outlets
blogs: 1 blog
twitter: 92 X users
patent: 1 patent

facebook: 1 Facebook page
reddit: 1 Redditor
video: 1 YouTube creator
podcasts: 3 podcasts

Readers on

mendeley: 115 Mendeley

So far, Altmetric has seen 104 X posts from 92 X users, with an upper bound of 1,088,350 followers.

RT @aditya_gan3500: @hankshas @witchdrkochi @MicieliA_MD Reference if somebody is interested https://t.co/sNH3GNLVc9

@hankshas @witchdrkochi @MicieliA_MD Reference if somebody is interested https://t.co/sNH3GNLVc9

RT @ShadiYaghi2: I hope this thread was helpful. For more information on TEMPO-2, attached is the link to the paper. Congratulations to Dr.…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 100 additional X posts.